BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24780461)

  • 1. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel biomarkers for diabetic nephropathy].
    Araki S
    Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic nephropathy: traditional to proteomic markers.
    Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
    Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
    Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
    J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients.
    Darmayanti S; Lesmana R; Meiliana A; Abdulah R
    Curr Diabetes Rev; 2021; 17(6):e123120189796. PubMed ID: 33393899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.
    Zubiri I; Posada-Ayala M; Benito-Martin A; Maroto AS; Martin-Lorenzo M; Cannata-Ortiz P; de la Cuesta F; Gonzalez-Calero L; Barderas MG; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
    Transl Res; 2015 Nov; 166(5):474-484.e4. PubMed ID: 26072307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy.
    Kishore L; Kaur N; Singh R
    Curr Diabetes Rev; 2017; 13(6):598-605. PubMed ID: 27924722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).
    Luo Y; Zhang W; Qin G
    Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 38963028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary exosomes and diabetic nephropathy: a proteomic approach.
    Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems biology: building a useful model from multiple markers and profiles.
    Mayer P; Mayer B; Mayer G
    Nephrol Dial Transplant; 2012 Nov; 27(11):3995-4002. PubMed ID: 23144070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of diabetic nephropathy: A 2017 update.
    Papadopoulou-Marketou N; Kanaka-Gantenbein C; Marketos N; Chrousos GP; Papassotiriou I
    Crit Rev Clin Lab Sci; 2017 Aug; 54(5):326-342. PubMed ID: 28956668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
    Lee SY; Choi ME
    Pediatr Nephrol; 2015 Jul; 30(7):1063-75. PubMed ID: 25060761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into predicting diabetic nephropathy using urinary biomarkers.
    Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
    Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
    Navarro JF; Milena FJ; Mora C; León C; García J
    Am J Nephrol; 2006; 26(6):562-70. PubMed ID: 17167242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
    Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
    J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in understanding the molecular pathogenesis of diabetic nephropathy].
    Abe H
    Rinsho Byori; 2011 Feb; 59(2):179-86. PubMed ID: 21476304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy.
    Fugmann T; Borgia B; Révész C; Godó M; Forsblom C; Hamar P; Holthöfer H; Neri D; Roesli C
    Kidney Int; 2011 Aug; 80(3):272-81. PubMed ID: 21544065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.